Sacubitril/Valsartan complex

Sacubitril/Valsartan complex (CAS 936623-90-4) is a pharmaceutical-grade cardiology combination compound in crystalline polymorphic form, manufactured directly by Polpharma with samples available and European Pharmacopoeia (EP) compliance. The combination medicine is used in adults, and children aged 1 and older, with chronic heart failure to lower the risk of hospitalization and death from worsening symptoms; note that in patent-protected markets such as Poland, the supplier states this product is developed only for regulatory/R&D purposes or export to non-EU countries under SPC exemption, not general sale. It is offered across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.